Monday, October 22, 2018

Yiannis Vlontzos

Vice – President, Responsible for HTA and Negotiation, Hellenic Association of Pharmaceutical Companies (SFEE), President and Managing Director of Merck

Yiannis Vlontzos
Yiannis Vlontzos

Yiannis Vlontzos has been a Merck Group Executive for more than 17 years. In October 2017, he assumed the position of Managing Director at Merck SA, responsible for Greek and Cypriot markets. Prior to that, he was the Head of Intercontinental Region (2014-2017) with the responsibility of one of the largest geographic regions (Russia, CIS countries, Turkey, ME, Africa), successfully delivering further growth to Merck business.

He was also the Managing Director at Merck Hellas for the period 2004-2014. Yiannis has been a member of the Financial Services of several large multinational corporations and has also served as VP of SFEE (Hellenic Association of Pharmaceutical Companies) in the past. He holds a degree in Business Administration from the Athens University of Economics (ASOEE, 1980-1986) and a Postgraduate Diploma in Business Information Technology Systems, University of Strathclyde (Strathclyde Business School, 1986-1987).

International Speakers

Michael Drummond Mike Drummond is Professor of Health Economics and was Director of the Centre from December 1995 to September 2005. His particular field of interest is in the economic evaluation of health care treatments and programmes.
Dr Panos Kanavos Panos Kanavos (BSc, MSc (Oxon), MSc (LSE), PhD) is Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health.
Katarzyna Kolasa, PhD Katarzyna Kolasa has more than 16 years of working experience in the healthcare sector, with 10 years with the pharmaceutical and medical devices industry and six with the public payer.
Vladimir Zah Vladimir Zah, PhD(c), brings 20+ years of Health Economics technology and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 170 health economic models and assessments in the phase 2, 3 and 4 settings, across various disease areas for top 20 global pharmaceutical companies; work supported with over 50 publications.

© 2018 Boussias Communications, all rights reserved., T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team